Brian Cahill - Feb 2, 2024 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Feb 2, 2024
Transactions value $
-$5,464
Form type
4
Date filed
2/6/2024, 05:09 PM
Previous filing
Jan 9, 2024
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$5.46K -934 -2% $5.85 45.7K Feb 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.